Strategic Partnerships Leverage past and ongoing collaborations with Biogen, Novartis AveXis, Opus Genetics, and Mass General/Harvard affiliations to propose joint development initiatives, licensing opportunities, or co-sponsored research programs in ophthalmic gene therapy and retina disease pipelines.

Gene Therapy Focus Position Masseyeassociates as a hub for advanced gene therapy and viral vector research related to inherited retinal diseases and COVID-19 vaccine vectors, offering contract research, access to clinical trial sites, and co-development opportunities with bio/pharma and academic partners.

Clinical and Surgical Expertise Highlight the breadth of ophthalmological and surgical capabilities to offer white-label or concierge ophthalmology services to larger health systems, potential center-of-excellence partnerships, and referral networks for complex eye care requiring specialized equipment and expertise.

Growth and Capacity With a mid-sized team and revenue in the multi-million range, pursue opportunities to expand service lines or satellite clinics via joint ventures, managed services agreements, or equipment-sharing arrangements to broaden geographic reach and patient access.

Technology Enablement Utilize tech stack strengths (WordPress, Webflow, iCIMS, analytics tools) to propose digital health collaborations, patient acquisition partnerships, and data-driven outcomes programs that appeal to hospitals, payers, and life sciences partners seeking measurable engagement.